More on MOOD
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $44.60 |
|
|||
| Open | $44.52 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $44.77 | ||||
| Day Low | $44.52 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 13,699 | ||||
- Doseology Announces Resignation of Director
- Doseology Announces Director and Officer Changes; Completes Shares-for-Debt Settlement
- Doseology Announces Proposed Shares-for-Debt Settlement and Resignation of Director
- Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category
- Doseology Launches Feed That Brain® Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot
- THE SIGNAL ARCHITECTURE: 5 Stocks Calibrating the 2026 Infrastructure Cycle
- Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors
- 5 Stocks Sitting on the Right Side of the Biggest Repricing in a Generation
- 2026 Asset Growth: Why Federal Compliance Is the New Metric
- THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle
Entities mentioned with MOOD
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Vanguard | View Related Stories »
- JPMorgan | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
